Ambrilia Biopharma, Inc. Report issue

For profit Phase 1 Phase 3
Founded: Montreal Canada (2006)
Status: Defunct (2011)

Organization Overview

First Clinical Trial
2006
NCT00695851
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now